Sign In
Buy MNMD
$20.69
+0 (+0%)
At Close: Jun 18, 2026
MindMed Announces Participation at Upcoming Investor Conferences
07:30am, Tuesday, 21'st Sep 2021
NEW YORK, Sept. 21, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, toda
MindMed to Present at H.C. Wainwright 23rd Annual Global Investment Conference
07:30am, Friday, 10'th Sep 2021
NEW YORK, Sept. 10, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pl
7 Penny Stocks Waiting on The FDA for Rocket Fuel
12:43pm, Thursday, 09'th Sep 2021
News of regulatory approval or progress would really help to move the needle for these seven biotech penny stocks. The post 7 Penny Stocks Waiting on The FDA for Rocket Fuel appeared first on Investor
MindMed to Attend 8th Annual "Mobile in Clinical Trials" Conference
07:30am, Thursday, 09'th Sep 2021
NEW YORK, Sept. 9, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pl
Time to Buy the Magic Stocks? Magic Mushrooms, That Is.
12:39pm, Wednesday, 08'th Sep 2021
The first state to legalize cannabis for medical use was California, in 1996. In 2001, medical marijuana was approved in Canada.
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
07:30am, Thursday, 02'nd Sep 2021
NEW YORK, Sept. 2, 2021 /PRNewswire/ -- MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, and BioXcel Therapeutics, In
Mind Medicine: Short-Term Catalysts Fall Flat
08:44am, Monday, 23'rd Aug 2021
Inclusion in the MSCI and FTSE Indices led to short-term gains that quickly evaporated.
MindMed: A Compelling Long-Term Buy In Biotech
06:17pm, Sunday, 22'nd Aug 2021
The acceptance of psychedelic treatments has been expedited over the past couple years, leaving companies like MindMed in great early positions to succeed. Normally, I would stay away from investing i
MindMed Joins Critical Path Institute's Patient-Reported Outcome Consortium
07:30am, Tuesday, 17'th Aug 2021
NEW YORK, Aug. 17, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, has jo
Mind Medicine (MindMed) Inc. (MNMD) CEO Robert Barrow on Q2 2021 Results - Earnings Call Transcript
06:53pm, Monday, 16'th Aug 2021
Mind Medicine (MindMed) Inc. (MNMD) CEO Robert Barrow on Q2 2021 Results - Earnings Call Transcript
Push the Boundaries of DMT Therapy with Mind Medicine
04:47pm, Monday, 16'th Aug 2021
Ready to explore an under-developed area of psychedelic medicine? If so, then consider a long position in low-priced MNMD stock.
MindMed Reports Q2 Earnings With Net Loss of $36M And Cash Balance Of $157M To Continue With Its Clinical Pipeline
08:54am, Monday, 16'th Aug 2021
The psychedelics-focused medicines company MindMed (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ), announced its second-quarter financial results Friday with a net and comprehensive loss of $36 million
MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline
11:50pm, Thursday, 12'th Aug 2021
NEW YORK, Aug. 12, 2021 /PRNewswire/ -- MindMed (Nasdaq: MNMD), (NEO: MMED), (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, has announced its quarterly financial resu
10 Penny Stocks to Buy to Create a $500 Portfolio
02:00pm, Wednesday, 11'th Aug 2021
These ten low-priced penny stocks have ample room to gain, making them each worthy of a small, speculative investment. The post 10 Penny Stocks to Buy to Create a $500 Portfolio appeared first on Inve
No Matter How the Pandemic Rolls, Mind Medicine Will Prevail
06:00am, Wednesday, 11'th Aug 2021
While MNMD stock is controversial due to its underlying psychedelic therapies, the broader narrative is exceptionally compelling. The post No Matter How the Pandemic Rolls, Mind Medicine Will Prevail
